AZGP1 and Familial prostate cancer: Reports demonstrated that poorly differentiated tumors expressed less AZGP1 than well differentiated tumors in most of popular human tumors, such as breast cancer, prostate cancer, oral squamous cell carcinomas, epidermal tumors, sweat gland tumors, pancreatic cancer and cervical cancer [13,15,16,26-30].